Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Talzenna, talazoparib, Date of authorisation: 20/06/2019, Revision: 9, Status: Authorised

ICH M10 on bioanalytical method validation - Scientific guideline

Plasma master file certificates

Real-world evidence

Big data

Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence

Reflection paper on use of real-world data in non-interventional studies to generate real-world evidence - Scientific guideline

Template for scientific document (part B-F)

CVMP Interested Parties’ meeting, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2024, 17:00 (CEST) to 22 May 2024, 19:00 (CEST)